Palatin Technologies PTN
NASDAQ PTN
$12.02 -0.31 (-2.51%)
At close: Sep 10, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Assets (2011 - 2026)

Palatin Technologies' (PTN) quarterly Assets came in at $13.2 million in Q1 2026, up 254.71% on a YoY basis from $3.7 million in Q1 2025, and down 26.23% quarter-over-quarter from $17.9 million in Q4 2025.

Analysis

Palatin Technologies (PTN) Assets (2011 - 2026) Analysis & Trends

Palatin Technologies (PTN) has reported Assets for 15 consecutive years, with $13.2 million the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Assets rose 254.71% year-over-year to $13.2 million; the trailing twelve-month figure through Mar 2026 stood at $13.2 million (up 254.71% YoY), and the FY2025 full-year result was $3.3 million, down 69.59% from the prior year.
  • Assets eased to $13.2 million in Q1 2026 per PTN's latest filing, from $17.9 million in the prior quarter.
  • Across five years, Assets topped out at $43.8 million in Q1 2022 and bottomed at $3.3 million in Q2 2025.
  • Historically, Assets has averaged $16.7 million across 5 years, with a median of $13.2 million in 2026.
  • The sharpest annual moves came in 2024 and 2025: Assets sank 69.64% in 2024, then jumped 315.95% in 2025.
  • Over 5 years, Assets stood at $32.0 million in 2022, then plunged by 57.61% to $13.6 million in 2023, then sank by 68.2% to $4.3 million in 2024, then surged by 315.95% to $17.9 million in 2025, then declined by 26.23% to $13.2 million in 2026.
  • According to Business Quant data, Assets over the past three periods registered $13.2 million, $17.9 million, and $8.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 95.64 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 49.36 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 27.42 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 41.73 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 10.03 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 10.96 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 5.56 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 32.09 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 5.31 Bn
10 Palatin Technologies 46.98 Mn 46.98 Mn - 13.23 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 13.23 Mn
Dec 31, 2025 17.93 Mn
Sep 30, 2025 8.61 Mn
Jun 30, 2025 3.27 Mn
Mar 31, 2025 3.73 Mn
Dec 31, 2024 4.31 Mn
Sep 30, 2024 3.42 Mn
Jun 30, 2024 10.74 Mn
Mar 31, 2024 11.41 Mn
Dec 31, 2023 13.55 Mn
Sep 30, 2023 11.25 Mn
Jun 30, 2023 17.94 Mn
Mar 31, 2023 25.61 Mn
Dec 31, 2022 31.98 Mn
Sep 30, 2022 27.64 Mn
Jun 30, 2022 36.07 Mn
Mar 31, 2022 43.82 Mn
Dec 31, 2021 52.99 Mn
Sep 30, 2021 59.73 Mn
Jun 30, 2021 67.30 Mn